Update on alpha-methyldopa
Farsang, C.
Therapia Hungarica 34(3): 139-149
1986
ISSN/ISBN: 0133-3909 PMID: 3126555 Document Number: 286095
Document emailed within 1 workday
Related Documents
Clineschmidt, B.V.; Flataker, L.M.; Faison, E.P.; Haubrich, D.R. 1980: Alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors Archives Internationales de Pharmacodynamie et de Therapie 244(2): 231-243Taylor, P.; Gillman, P.K.; Gaind, R. 1978: Alpha-methyldopa in schizophrenia Journal of Clinical Psychiatry 39(11): 815-816
Kaplinsky, N.; Fraenkel, O. 1972: Hemolytic anemia due to alpha-methyldopa Harefuah 83(11): 487-488
Koller, O.; Lehoczky, D. 1976: Immune hemolysis in the course of alpha methyldopa therapy Orvosi Hetilap 117(9): 545-546
Uspenskiĭ, A.E.; Korobov, N.V. 1976: Facilitation of the effects of L-DOPA by alpha-methyldopa Biulleten' Eksperimental'noi Biologii i Meditsiny 81(3): 314-316
Chouinard, G.; Pinard, G.; Prenoveau, Y.; Tetreault, L. 1973: Alpha methyldopa-chlorpromazine interaction in schizophrenic patients Current Therapeutic Research 15(2): 60-72
Káldor, A.; Kállay, K.; Sebestyén, K.; Alexits, K. 1972: The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man Orvosi Hetilap 113(1): 23-24
Uretsky, N.J. 1974: Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat Journal of Pharmacology and Experimental Therapeutics 189(2): 359-369
Beretta, R.; Cassi, E.; Colombo, A.; De Paoli, A.; Marciandi, C.; Renzetti, G.A. 1982: Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic La Clinica Terapeutica 103(5): 487-500
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Mantia, G.; Hopps, V.; Leone, F.; Consiglio, D. 1971: Influence of alpha-methyldopa on the glycide metabolism changes induced by vagotomy Bollettino della Societa Italiana di Biologia Sperimentale 47(22): 738-741
Yahr, M.D.; Duvoisin, R.C.; Mendoza, M.R.; Schear, M.J.; Barrett, R.E. 1971: Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association 96: 55-58
Adithan, C.; Venkataraman, B.V.; Joseph, T. 1982: Effect of alpha-Methyldopa on Physostigmine induced pressor response in rats Indian Journal of Experimental Biology 20(11): 842-844
Seedat, Y.K.; Vawda, E.I.; Mitha, S.; Ramasar, R. 1970: A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension South African Medical Journal 44(10): 300-301
Hauser, G.J.; Almog, S.; Tirosh, M.; Spirer, Z. 1985: Effect of alpha-methyldopa excreted in human milk on the breast-fed infant Helvetica Paediatrica Acta 40(1): 83-86
Giordano, G.; Minuto, F.; Foppiani, E.; Marugo, M.; Barreca, T. 1973: Behavior of the somatotropin peak during sleep under the influence of alpha-methyldopa and disulfiram Bollettino della Societa Italiana di Biologia Sperimentale 49(21): 1230-1235
Campbell, N.R.; Campbell, R.R.; Hasinoff, B.B. 1990: Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism Clinical and Investigative Medicine. Medecine Clinique et Experimentale 13(6): 329-332
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease Australian and New Zealand Journal of Medicine 4(4): 373-378
During, R.; Schwarzlos, G. 1985: Effect of alpha-methyldopa (Dopegyt) on blood pressure in hypertensive pregnant patients Zentralblatt für Gynakologie 107(6): 357-362
Wiggins, J.F.; Sved, A.F.; Fernstrom, J.D. 1980: Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies Journal of Pharmacology and Experimental Therapeutics 212(2): 304-308